SAM
USNA icon

Smartleaf Asset Management’s Usana Health Sciences USNA Stock Holding History

Smartleaf Asset Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12
Closed -$423 – 3009
2024
Q4 		$423 Buy
+12
New +$449 ﹤0.01% 2805

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Smartleaf Asset Management's USNA Position: Q1 2025 in Review

Smartleaf Asset Management sold out of Usana Health Sciences (USNA) in Q1 2025, closing a stake of 12 shares — an estimated $423 sold.

Smartleaf Asset Management first reported a position in USNA in Q4 2024 and held it in 1 quarter. The position peaked at $423 in Q4 2024. 162 funds tracked by Wall St. Rank hold USNA as of Q1 2025.

  • Smartleaf Asset Management reported no remaining Usana Health Sciences position as of Q1 2025 after selling out during the quarter.
  • Smartleaf Asset Management sold 12 Usana Health Sciences shares in Q1 2025, an estimated $423.
  • Smartleaf Asset Management first reported a position in Usana Health Sciences in Q4 2024 and held it in 1 quarter.
  • Smartleaf Asset Management's Usana Health Sciences position peaked at $423 in Q4 2024.
  • 162 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2025.

Based on Smartleaf Asset Management's 13F filing for Q1 2025, filed 14 May 2025.